AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
209.40
-1.72 (-0.81%)
At close: Mar 27, 2026, 4:00 PM EDT
209.75
+0.35 (0.17%)
Pre-market: Mar 30, 2026, 6:21 AM EDT
AbbVie (ABBV) Operating Expense Breakdown
History
| Date | Selling, General, and Administrative | Acquired In-Process R&D | Research and Development | Other Expenses |
|---|---|---|---|---|
| Sep 30, 2025 | 13.97B | 5.33B | 13.29B | - |
| Jun 30, 2025 | 14.61B | 2.73B | 13.10B | - |
| Mar 31, 2025 | 14.73B | 2.84B | 12.92B | -48.00M |
| Dec 31, 2024 | 14.75B | 2.76B | 12.79B | -31.00M |
| Sep 30, 2024 | 14.09B | 1.47B | 7.94B | - |
| Jun 30, 2024 | 13.26B | 1.45B | 7.54B | - |
| Mar 31, 2024 | 13.15B | 792.00M | 7.32B | -14.00M |
| Dec 31, 2023 | 12.87B | 778.00M | 7.68B | -7.00M |
| Sep 30, 2023 | 13.10B | 739.00M | 7.54B | - |
| Jun 30, 2023 | 13.03B | 713.00M | 7.43B | - |
| Mar 31, 2023 | 15.17B | 702.00M | 7.31B | - |
| Dec 31, 2022 | 15.26B | 697.00M | 6.51B | - |
| Sep 30, 2022 | 15.10B | 859.00M | 6.55B | - |
| Jun 30, 2022 | 14.88B | 1.22B | 6.59B | - |
| Mar 31, 2022 | 12.63B | 1.08B | 6.75B | - |
| Dec 31, 2021 | 12.35B | 1.12B | 6.92B | - |
| Sep 30, 2021 | 12.32B | 1.02B | 6.99B | - |
| Jun 30, 2021 | 12.08B | 662.00M | 7.03B | - |
| Mar 31, 2021 | 12.45B | 1.38B | 6.85B | -358.00M |
| Dec 31, 2020 | 11.30B | 1.20B | 6.56B | -190.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.